Ascentage Pharma Group International (36X0)
Market Open
11 Jun, 13:26
XFRA XFRA Primary 
NASDAQ (NMS) €
13. 60
-0.9
-6.2069%
€
1.34B Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
€ 14.5
Previous Close Want to track 36X0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ascentage Pharma Group International (36X0) Statistics
Valuation metrics
Market Cap 1.34B
Enterprise value 609.21M
Trailing P/E (ttm) -1.03
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.31
Price/Book (mrq) 7.81
Enterprise Value/Revenue 8.33
Enterprise Value/EBITDA -4.2
Overview
Shares outstanding 373.32M
Float 284.27M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 30
Average volume (90 days) 41
Price summary
52-Week low 13.6
52-Week high 40
Beta 0.72
50-Day moving average 18.61
200-Day moving average 23.53
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.16%
Operating margin -1.93%
Operational effectiveness
Return on assets -0.23%
Return on equity -1.55%
Income Statement
Revenue (ttm) 73.16M
Revenue per share (ttm) 6.45
Quarterly revenue growth (yoy) 1.17%
Gross profit (ttm) 66.92M
EBITDA -144.97M
Net income to common (ttm) -158.37M
Diluted EPS (ttm) -1.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 315.04M
Total cash per share (mrq) 6.67
Total debt (mrq) 252.28M
Total Debt/Equity (mrq) 148.38
Current ratio (mrq) 1.79%
Book value per share (mrq) 1.82
Cash Flow
Cash flow statement -149.62M
Levered free cash flow (LFCF) -120.12M
